By Josh White
Date: Tuesday 27 Aug 2024
(Sharecast News) - Diaceutics announced a significant enhancement to its rare-disease offerings on Tuesday, leading to the acquisition of a new contract aimed at supporting the commercialisation of a rare-disease therapy.
By Iain Gilbert
Date: Monday 19 Aug 2024
(Sharecast News) - Technology and solutions provider Diaceutics has struck a "groundbreaking enterprise promotional partnership" with a "leading biotech" firm worth up to £4.3m over 18 months.
By Iain Gilbert
Date: Thursday 16 May 2024
(Sharecast News) - Technology and solutions provider Diaceutics has struck two new enterprise-wide agreements, taking the total number to six engagements, across 29 separate therapeutic brands.
Currency | UK Pounds |
Share Price | 117.50p |
Change Today | -1.00p |
% Change | -0.84 % |
52 Week High | 134.00 |
52 Week Low | 84.50 |
Volume | 5,293 |
Shares Issued | 84.68m |
Market Cap | £99.50m |
Beta | 0.15 |
RiskGrade | 196 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
14:26 | 5,000 @ 117.10p |
13:19 | 268 @ 118.15p |
11:20 | 2 @ 120.00p |
11:20 | 7 @ 117.00p |
11:20 | 16 @ 117.00p |
CEO | Ryan Gerard Keeling |
CFO | Nick Roberts |
You are here: research